COVID-19 recurrence is related to disease-early profile T cells while detection of anti-S1 IgG is related to multifunctional T cells.
Camilla Natália O SantosGustavo C CaldasFabricia A de OliveiraAngela Maria da SilvaJoão S da SilvaRicardo Luís L da SilvaAmélia R de JesusLucas Sousa MagalhãesRoque P de AlmeidaPublished in: Medical microbiology and immunology (2023)
COVID-19 is caused by SARS-CoV-2 infection and leads from asymptomatic to severe outcomes. The recurrence of the COVID-19 has been described, however, mechanisms involved remains unclear. Thus, the work aimed to investigate the role of multifunctional T cells in patients with recurrent COVID-19. We evaluated clinical characteristics, presence of anti-S1 and anti-Nucleocapsid IgG in patients' sera, and multifunctional T cells (for IFN-γ, IL-2, and TNF-α) in patients with multiple episodes of COVID-19 and controls. Data demonstrate that patients with recurrent COVID-19 have a T cell pattern predominantly related to IFN-γ production. Also, patients with COVID-19 history and absence of anti-S1 IgG had lower levels of CD4+ IFN + IL-2 + TNF + T cells independently of number of disease episodes. Complementary, vaccination changed the patterns of T cells phenotypes and induced IgG seroconversion, despite not induce higher levels of multifunctional T cells in all patients. In conclusion, the data suggest that recurrent disease is related to early-disease T cell profile and absence of anti-S1 IgG is related to lower multifunctional CD4 T cell response, what suggests possibility of new episodes of COVID-19 in these patients.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- drug delivery
- newly diagnosed
- ejection fraction
- respiratory syndrome coronavirus
- chronic kidney disease
- rheumatoid arthritis
- peritoneal dialysis
- prognostic factors
- immune response
- cancer therapy
- dendritic cells
- oxidative stress
- type diabetes
- patient reported outcomes
- real time pcr